**Trader consensus on "No" at 94.5% reflects the absence of any novel pathogen exhibiting sustained human-to-human transmission through mid-August 2026.** Official surveillance from CDC and WHO shows only sporadic zoonotic cases, such as 71 U.S. H5N1 infections linked primarily to animal exposure with no person-to-person spread, alongside contained Ebola Bundibugyo activity in the DRC and Uganda and routine seasonal respiratory trends at low levels. Post-COVID enhancements in genomic monitoring, rapid diagnostics, and international coordination have enabled early detection of threats without escalation to pandemic thresholds. Realistic scenarios that could shift odds include a highly transmissible H5N1 variant or an unknown "Disease X" emerging with efficient respiratory spread before year-end, though current model consensus and case patterns indicate low near-term likelihood.